Shelley W Collins

Shelley W Collins, M.D., FAAP

Professor Of Pediatrics

Department: MD-PEDS-HOSPITALIST PROGRAM
Business Phone: (352) 273-5400
Business Email: swcgator@peds.ufl.edu

About Shelley W Collins

Shelley W. Collins, MD, attended the University of Miami Miller School of Medicine for medical school and stayed at Jackson Memorial Hospital to complete her pediatric residency and chief residency.After working in private practice in Maryland and as a pediatric hospitalist at Children’s National Medical Center at George Washington University, Dr. Collins returned to Florida and joined the University of Florida faculty in 2006. She worked in the critical care division as well as the congenital heart center before being appointed chief of pediatric hospital medicine in 2009. She served in that role until 2013 when she was appointed as the UF Health Shands Children’s Hospital inpatient medical director. Dr. Collins was also appointed as the Associate Chief Medical Officer of UF Health in 2016.Helping to support the university’s mission to train and teach residents and medical students, Dr. Collins is very involved in the education of students at every level. She has an active role in several courses, clerkships and committees revolving around medical education. She also serves as a faculty adviser to residents and is active in residency education at the patient bedside. Dr. Collins is the Assistant Dean for Medical Education and is an Associate Pediatric Program Director.

Accomplishments

Inspirational Physician
2017 · AMA Women Physicians Section
Leadership and Management Foundations For Academic Medicine and Science
2016 · American Association of Medical Colleges
Society of Teaching Scholars Inductee
2015 · Society of Teaching Scholars

Board Certifications

  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties
  • Pediatrics

Publications

2021
A case report of primary amebic meningoencephalitis in North Florida.
IDCases. 25 [DOI] 10.1016/j.idcr.2021.e01208. [PMID] 34307045.
2018
Safety and effectiveness of albuterol solutions with and without benzalkonium chloride when administered by continuous nebulization.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(22):1791-1797 [DOI] 10.2146/ajhp180154. [PMID] 30282664.
2017
Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity.
Experimental neurology. 287(Pt 2):216-224 [DOI] 10.1016/j.expneurol.2016.07.013. [PMID] 27453480.
2017
Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.
Human gene therapy. Clinical development. 28(4):208-218 [DOI] 10.1089/humc.2017.146. [PMID] 29160099.
2016
Implementing a Quality and Safety Agenda in a Children’s Hospital Within a Hospital: Challenges and Successes.
Hospital pediatrics. 6(7):431-3 [DOI] 10.1542/hpeds.2015-0226. [PMID] 27302988.
2014
Acid Alpha-Glucosidase Gene Replacement Therapy To the Diaphragm Remodels Ventilatory Function in Severe Pompe Disease
The FASEB's Journal. 28(1, S)
2014
Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease.
Human gene therapy. Clinical development. 25(3):134-63 [DOI] 10.1089/humc.2014.2514. [PMID] 25238277.
2013
Acid Alpha-Glucosidase Gene Replacement Therapy To the Diaphragm in Ventilator-Dependent Pompe Disease: One-Year Respiratory Motor Outcomes
Molecular Therapy. 21:S23-S24
2013
B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.
The Journal of pediatrics. 163(3):847-54.e1 [DOI] 10.1016/j.jpeds.2013.03.002. [PMID] 23601496.
2013
One Year Outcomes of Diaphragm Gene Therapy in Ventilator Dependent Children With Pompe Disease
Molecular Genetics and Metabolism. 108(2) [DOI] 10.1016/j.ymgme.2012.11.047.
2013
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.
Human gene therapy. 24(6):630-40 [DOI] 10.1089/hum.2012.250. [PMID] 23570273.
2012
Phase I/Ii Trial of Adeno-Associated Virus Acid-Alpha-Glucosidase (Aav-Gaa) Diaphragm Gene Therapy for Ventilatory Failure in Pompe Disease
Molecular Genetics and Metabolism. 105(2) [DOI] 10.1016/j.ymgme.2011.11.039.
2012
Transition of care: what is the pediatric hospitalist’s role? An exploratory survey of current attitudes.
Journal of hospital medicine. 7(4):277-81 [DOI] 10.1002/jhm.936. [PMID] 22125023.
2011
Immune Modulation in Early Onset Pompe Disease
Molecular Genetics and Metabolism. 102(2):S31-S32 [DOI] 10.1016/j.ymgme.2010.11.107.
2011
Pompe disease gene therapy.
Human molecular genetics. 20(R1):R61-8 [DOI] 10.1093/hmg/ddr174. [PMID] 21518733.

Education

Residency – Pediatrics
2002 · University of Miami
Medical Degree
1999 · University of Miami

Teaching Profile

Courses Taught
2018
MDC7400 Pediatric Clerkship
2018
BMS6812 Intro Clin Med 2
2014-2015
MDC7401 Senior Pediatric Clk
2010-2014
BCC7141 Senior Pediatric Clk

Contact Details

Phones:
Business:
(352) 273-5400
Emails:
ADMINISTRATIVE SPECIALIST III:
Larry A Compton
View Profile